Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $88.70 +2.38%
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of ($0.20), $0.09 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $23.53 million versus the consensus estimate of $21.74 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
